M. Klint, R. Hadad, L. Christerson, B. Loré, C. Anagrius, A

Slides:



Advertisements
Similar presentations
Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages
Advertisements

Serotypes and clinical manifestations of invasive group B streptococcal infections in western Sweden   E. Persson, S. Berg, B. Trollfors, P.
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
P.-Y. Lévy  Clinical Microbiology and Infection 
L. Boyanova  Clinical Microbiology and Infection 
Changes in antimicrobial resistance, serotypes and genotypes in Streptococcus pneumoniae over a 30-year period  J. Liñares, C. Ardanuy, R. Pallares, A.
Gut bacterial microbiota and obesity
Approach to diagnosis of infective endocarditis
Varicella vaccination: a laboured take-off
S. Wagenpfeil, A. Neiss, K. Banz, P. Wutzler 
Herpes zoster in non-hospitalized children
European Society of Clinical Microbiology and Infectious Diseases (ESCMID): Data review and recommendations for diagnosing Clostridium difficile-infection.
Migrant health—a cause for concern?
Clinical characteristics of Haemophilus influenzae meningitis in Denmark in the post- vaccination era  T.I. Pedersen, M. Howitz, C. Østergaard  Clinical.
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
Gastroenteritis outbreak caused by norovirus associated with the children's club of a hotel located in Majorca, Spain  A. Doménech-Sánchez  Clinical Microbiology.
Emerging issues on hepatitis C virus infection after the introduction of the Directly Acting Antivirals  G. Ippolito  Clinical Microbiology and Infection 
J.-P. Van geertruyden  Clinical Microbiology and Infection 
Virological tools to diagnose and monitor hepatitis C virus infection
R. Cantón  Clinical Microbiology and Infection 
Genital Chlamydia trachomatis infections
P. Nordmann, L. Poirel  Clinical Microbiology and Infection 
Large-scale testing of women in Copenhagen has not reduced the prevalence of Chlamydia trachomatis infections  H. Westh, H.J. Kolmos  Clinical Microbiology.
E. Cambau, M. Drancourt  Clinical Microbiology and Infection 
Nocardiosis in Quebec, Canada, 1988–2008
Louis Pasteur, from crystals of life to vaccination
How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development  R. Bax  Clinical Microbiology.
G. Griesinger, G. Gille, C. Klapp, S. von Otte, K. Diedrich 
Chlamydia trachomatis infections in heterosexuals attending sexually transmitted disease clinics in Slovenia  D. Kese, M. Maticic, M. Potocnik  Clinical.
An eye-catching acanthocephalan
Should standardized susceptibility testing for microbial biofilms be introduced in clinical practice?  T. Coenye, D. Goeres, F. Van Bambeke, T. Bjarnsholt 
Prevalence of Toscana virus antibodies in residents of Croatia
Clinical Microbiology and Infection
Surveillance of Legionnaires’ disease in Austria
M. Nørgaard, H. Larsson, G. Pedersen, H.C. Schønheyder, H.T. Sørensen 
Vector control: a cornerstone in the malaria elimination campaign
Training for the infectious diseases speciality in Norway
A. Pan, R. Buttazzi, M. Marchi, C. Gagliotti, D. Resi, M.L. Moro 
Levofloxacin in the treatment of ventilator-associated pneumonia
G. Pappas  Clinical Microbiology and Infection 
Metagenomics and probiotics
Previously unknown species of Aspergillus
A case of pleurisy associated with antibodies to Rickettsia conorii
T. Norén, K. Johansson, M. Unemo  Clinical Microbiology and Infection 
The practice of travel medicine in Europe
T.M. File  Clinical Microbiology and Infection 
Systematic review of antibiotic consumption in acute care hospitals
Update on antifungal resistance in Aspergillus and Candida
Antibacterial drug discovery in the 21st century
Abstracts cont. Clinical Microbiology and Infection
Pandemic lineages of extraintestinal pathogenic Escherichia coli
Antimicrobial drug development – the past, the present, and the future
Circulation of international clones of levofloxacin non-susceptible Streptococcus pneumoniae in Taiwan  Y.-C. Hsieh, L.-Y. Chang, Y.-C. Huang, H.-C. Lin,
Presence of sandflies infected with Leishmania infantum and Massilia virus in the Marseille urban area†   B. Faucher, R. Piarroux, C. Mary  Clinical Microbiology.
Statin use and clinical outcomes among pneumonia patients
Clinical Microbiology and Infection
Listeriosis: a resurgent foodborne infection
A. Norberg, C.E. Nord, B. Evengård  Clinical Microbiology and Infection 
K. Kaier, N.T. Mutters, U. Frank  Clinical Microbiology and Infection 
Z. Erjavec, H. Kluin-Nelemans, P.E. Verweij 
The atypical pneumonias: clinical diagnosis and importance
Abstracts Clinical Microbiology and Infection
Virology: a scientific discipline facing new challenges
Modelling during an emergency: the 2009 H1N1 influenza pandemic
J.L. Balcázar  Clinical Microbiology and Infection 
G.C. Schito  Clinical Microbiology and Infection 
Impact of antibiotic restrictions: the patient's perspective
Comparative study of pediculicidal effect of medical plants
CMI readers' survey Clinical Microbiology and Infection
The future of diagnostic bacteriology
Presentation transcript:

Prevalence trends in Sweden for the new variant of Chlamydia trachomatis  M. Klint, R. Hadad, L. Christerson, B. Loré, C. Anagrius, A. Österlund, I. Larsson, S. Sylvan, H. Fredlund, M. Unemo, B. Herrmann  Clinical Microbiology and Infection  Volume 17, Issue 5, Pages 683-689 (May 2011) DOI: 10.1111/j.1469-0691.2010.03305.x Copyright © 2011 European Society of Clinical Infectious Diseases Terms and Conditions

Fig. 1 (a) Proportion of new variant Chlamydia trachomatis (nvCT) of all cases positive for C. trachomatis in two counties using the Roche system (blue/green) and two counties using the Becton Dickinson system (BD) (red/yellow). Differences were significant, with non‐overlapping 95% CIs in 2007. (b) Number of diagnosed cases of C. trachomatis from February to June per 100 000 inhabitants in the years 2007–2009. (c) Proportion of serotype E among wild‐type C. trachomatis (wtCT) specimens. The time‐points for collection of specimens presented in (a) and (c) are specified in Table 1. Clinical Microbiology and Infection 2011 17, 683-689DOI: (10.1111/j.1469-0691.2010.03305.x) Copyright © 2011 European Society of Clinical Infectious Diseases Terms and Conditions

Fig. 2 Positivity rate for C. trachomatis for different diagnostic methods in Sweden from 2004 to 2008. The classification of test method was based on the method used in 2005 and 2006, i.e. the time period prior to the discovery of new variant Chlamydia trachomatis and before detection systems were modified. Most counties with Abbott/Roche systems also had such systems in 2004. The positivity rate was calculated as the number of diagnosed C. trachomatis cases divided by the total number of tests. Clinical Microbiology and Infection 2011 17, 683-689DOI: (10.1111/j.1469-0691.2010.03305.x) Copyright © 2011 European Society of Clinical Infectious Diseases Terms and Conditions